跳至主要内容
临床试验/ISRCTN00283877
ISRCTN00283877已完成不适用

A multicentre study to determine the efficacy and patient acceptability of scalp cooling in the prevention of docetaxel-induced hair loss

eiden University Medical Centre (LUMC) (The Netherlands)0 个研究点目标入组 260 人开始时间: 2005年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
260

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Intravenous administered docetaxel regimes
  • 2. Age 18 years or more
  • 3. Written informed consent

排除标准

  • 1. Boldness before the start of the study
  • 2. Haematological malignancies with generalised haematogenic metastases (e.g. lymphoma, leukaemia and multiple myeloma) and if in those conditions chemotherapy is given with a curative intent
  • 3. Clinical signs of scalp metastases
  • 4. Cold sensitivity
  • 5. Cold agglutinin disease
  • 6. Cryoglobulinaemia
  • 7. Cryofibrinogenaemia

研究者

发起方
eiden University Medical Centre (LUMC) (The Netherlands)

相似试验